Transcriptional activation of the senescence regulator Lsh by E2F1

Mechanisms of Ageing and Development

Volumn 132, Issue 4, 2011, Pages 180-186

  Niu, Jing ^a   Chen, Tianda ^a   Han, Limin ^a   Wang, Pan ^a   Li, Na ^a   Tong, Tanjun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cellular senescence; E2F1; Lsh; Transcriptional regulation

Indexed keywords

ADENOSINE TRIPHOSPHATASE; PROTEIN LSH; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL AGING; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LSH GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ADENOSINE TRIPHOSPHATASES; BINDING SITES; CELL AGING; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA HELICASES; E2F1 TRANSCRIPTION FACTOR; FIBROBLASTS; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION;

EID: 79955786911     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2011.03.004     Document Type: Article

References (46)

1. Bates S., Phillips A.C., Clark P.A., Stott F., Peters G., Ludwiq R.L., Vousden K.H. p14ARF links the tumour suppressors RB and p53. Nature 1998, 395:124-125.
2. Bell L.A., Ryan K.M. Life and death decisions by E2F-1. Cell Death Differ. 2004, 11:137-142.
3. Chiang S.Y., Azizkhan J.C., Beerman T.A. A comparison of DNA-binding drugs as inhibitors of E2F1- and Sp1-DNA complexes and associated gene expression. Biochemistry 1998, 37:3109-3115.
4. Chiang S.Y., Bruice T.C., Azizkhan J.C., Gawron L., Beerman T.A. Targeting E2F1-DNA complexes with microgonotropen DNA binding agents. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:2811-2816.
5. De La Fuente R., Baumann C., Fan T., Schmidtmann A., Dobrinski I., Muegge K. Lsh is required for meiotic chromosome synapsis and retrotransposon silencing in female germ cells. Nat. Cell Biol. 2006, 8:1448-1454.
6. DeGregori J., Leone G., Miron A., Jakoi L., Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:7245-7250.
7. Dennis K., Fan T., Geiman T., Yan Q., Muegge K. Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev. 2001, 15:2940-2944.
8. Dicker A.J., Popa C., Dahler A.L., Serewko M.M., Hilditch-Maguire P.A., Frazer I.H., Saunders N.A. E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes. Oncogene 2000, 19:2887-2894.
9. Dimri G.P., Hara E., Campisi J. Regulation of two E2F-related genes in presenescent and senescent human fibroblasts. J. Biol. Chem. 1994, 269:16180.
10. Dimri G.P., Itahana K., Acosta M., Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol. Cell. Biol. 2000, 20:273-285.
11. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998, 12:2245-2262.
12. Fan T., Yan Q., Huang J., Austin S., Cho E., Ferris D., Muegge K. Lsh-deficient murine embryonal fibroblasts show reduced proliferation with signs of abnormal mitosis. Cancer Res. 2003, 63:4677-4683.
13. Geiman T.M., Durum S.K., Muegge K. Characterization of gene expression, genomic structure, and chromosomal localization of Hells (Lsh). Genomics 1998, 54:477-483.
14. Geiman T.M., Muegge K. Lsh, an SNF2/helicase family member, is required for proliferation of mature T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4772-4777.
15. Geiman T.M., Tessarollo L., Anver M.R., Kopp J.B., Ward J.M., Muegge K. Lsh, a SNF2 family member, is required for normal murine development. Biochim. Biophys. Acta 2001, 1526:211-220.
16. Hasty P., Campisi J., Hoeijmakers J., van Steeg H., Vijg J. Aging and genome maintenance: lessons from the mouse?. Science 2003, 299:1355-1359.
17. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 1965, 37:614-636.
18. Hsieh J.K., Yap D., O'Connor D.J., Fogal V., Fallis L., Chan F., Zhong S., Lu X. Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Mol. Cell. Biol. 2002, 22:78-93.
19. Ishizaki J., Nevins J.R., Sullenger B.A. Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nat. Med. 1996, 2:1386-1389.
20. Jarvis C.D., Geiman T., Vila-Storm M.P., Osipovich O., Akella U., Candeias S., Nathan I., Durum S.K., Muegge K. A novel putative helicase produced in early murine lymphocytes. Gene 1996, 169:203-207.
21. Johnson D.G., Cress W.D., Jakoi L., Nevins J.R. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:12823-12827.
22. Johnson D.G., Schwarz J.K., Cress W.D., Nevins J.R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993, 365:349-352.
23. Jones S.J., Dicker A.J., Dahler A.L., Saunders N.A. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development. J. Invest. Dermatol. 1997, 109:187-193.
24. Kowalik T.F., DeGregori J., Schwarz J.K., Nevins J.R. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 1995, 69:2491-2500.
25. Maeshima Y., Kashihara N., Yasuda T., Sugiyama H., Sekikawa T., Okamoto K., Kanao K., Watanabe Y., Kanwar Y.S., Makino H. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J. Clin. Invest. 1998, 101:2589-2597.
26. Miyajima M., Nornes H.O., Sato K., Neuman T. Overexpression of E2F1 in astrocytes leads to neoplastic transformation and changes in expression of retinoblastoma family members. J. Neurosci. Res. 1996, 46:108-113.
27. Morishita R., Gibbons G.H., Horiuchi M., Ellison K.E., Nakama M., Zhang L., Kaneda Y., Ogihara T., Dzau V.J. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:5855-5859.
28. Muegge K. Lsh, a guardian of heterochromatin at repeat elements. Biochem. Cell Biol. 2005, 83:548-554.
29. Muller H., Bracken A.P., Vernell R., Moroni M.C., Christians F., Grassilli E., Prosperini E., Vigo E., Oliner J.D., Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 2001, 15:267-285.
30. Nahle Z., Polakoff J., Davuluri R.V., McCurrach M.E., Jacobson M.D., Narita M., Zhang M.Q., Lazebnik Y., Bar-Sagi D., Lowe S.W. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 2002, 4:859-864.
31. Pazolli E., Stewart S.A. Senescence: the good the bad and the dysfunctional. Curr. Opin. Genet. Dev. 2008, 18:42-47.
32. Phillips A.C., Bates S., Ryan K.M., Helin K., Vousden K.H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 1997, 11:1853-1863.
33. Raabe E.H., Abdurrahman L., Behbehani G., Arceci R.J. An SNF2 factor involved in mammalian development and cellular proliferation. Dev. Dyn. 2001, 221:92-105.
34. Saito M., Helin K., Valentine M.B., Griffith B.B., Willman C.L., Harlow E., Look A.T. Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line. Genomics 1995, 25:130-138.
35. Sun L.Q., Lee D.W., Zhang Q., Xiao W., Raabe E.H., Meeker A., Miao D., Huso D.L., Arceci R.J. Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene. PASG Genes Dev. 2004, 18:1035-1046.
36. Tang Z., Zhang Z., Zheng Y., Corbley M.J., Tong T. Cell aging of human diploid fibroblasts is associated with changes in responsiveness to epidermal growth factor and changes in HER-2 expression. Mech. Ageing Dev. 1994, 73:57-67.
37. Wang W., Martindale J.L., Yang X., Chrest F.J., Gorospe M. Increased stability of the p16 mRNA with replicative senescence. EMBO Rep. 2005, 6:158-164.
38. Wang W., Wu J., Zhang Z., Tong T. Characterization of regulatory elements on the promoter region of p16(INK4a) that contribute to overexpression of p16 in senescent fibroblasts. J. Biol. Chem. 2001, 276:48655-48661.
39. Wei W., Hemmer R.M., Sedivy J.M. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 2001, 21:6748-6757.
40. Wu X., Levine A.J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:3602-3606.
41. Xi S., Geiman T.M., Briones V., Guang Tao Y., Xu H., Muegge K. Lsh participates in DNA methylation and silencing of stem cell genes. Stem Cells 2009, 27:2691-2702.
42. Xu G., Livingston D.M., Krek W. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:1357-1361.
43. Zheng Q.H., Ma L.W., Zhu W.G., Zhang Z.Y., Tong T.J. p21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylation. J. Cell. Biochem. 2006, 98:1230-1248.
44. Zhou R., Han L., Li G., Tong T. Senescence delay and repression of p16INK4a by Lsh via recruitment of histone deacetylases in human diploid fibroblasts. Nucleic Acids Res. 2009, 37:5183-5196.
45. Zhu H., Geiman T.M., Xi S., Jiang Q., Schmidtmann A., Chen T., Li E., Muegge K. Lsh is involved in de novo methylation of DNA. Embo J. 2006, 25:335-345.
46. Zindy F., Eischen C.M., Randle D.H., Kamijo T., Cleveland J.L., Sherr C.J., Roussel M.F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 1998, 12:2424-2433.